With that being explained, devoid of human trials there is not any way to truly assess exactly how much YK11 can inhibit Myostatin in people (if in any way), and when there is a dosage which could equate to the same standard of Myostatin inhibition that a genetic anomaly by using a gene mutation has.YK11 differs from common SARMs like LGD-4033 and … Read More